W.WeivodaM
Accumulation of these cells is associated with poor function in multiple organs, including the heart, blood vessels, kidneys, muscles, bones and brain
5.1.1 Rapamycin Rapamycin, a macrolide compound derived from Streptomyces hygroscopicus , has attracted attention not only for its effective immunosuppressive properties but also for its impact on longevity, as it is the first pharmacological compound shown to extend lifespan in mammals (Harrison et al., 2009
2024 Aug 2;19(1):61
CagriSema's Advantages: First to Market: 6-12 month head start Leverages Wegovy Success: Built-in brand recognition Proven Semaglutide Component: Half the drug is already approved Strong Diabetes Data: Positions for dual indication No Dysesthesia: Cleaner safety profile in one key area Retatrutide's Advantages: Higher Efficacy: 28.7% vs 20.4% (8.3 points more) Superior BP Reduction: -14 mmHg vs likely similar to semaglutide Single Molecule: Potentially easier manufacturing Multiple Indications: OA, OSA, obesity, diabetes trials Novel Class: First triple agonist = strong IP protection The Verdict: Market Will Support Both These medications won't compete head-to-head
It has a well-support safety profile: a comprehensive 2025 review found minimal toxicity with no evidence of carcinogenicity
